Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "ARV"

293 News Found

Resilience and Harvard announce five-year R&D alliance
News | October 18, 2021

Resilience and Harvard announce five-year R&D alliance

First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders


Morpen Labs carves out diagnostics business to unlock value
Clinical Trials | September 29, 2021

Morpen Labs carves out diagnostics business to unlock value

The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India


Remdesivir demand was exaggerated: Dr. Sharvil Patel
News | May 28, 2021

Remdesivir demand was exaggerated: Dr. Sharvil Patel

Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines


Aurobindo Pharma Q4 FY26 revenue rises 5.6% to Rs. 8,853 crore
News | May 22, 2026

Aurobindo Pharma Q4 FY26 revenue rises 5.6% to Rs. 8,853 crore

Net profit stood at Rs. 921 crore for the quarter, while Europe revenues surged 30.2% YoY to Rs. 2,795 crore


Zydus Lifesciences reports FY26 revenue of Rs. 27,148 crore, Q4 revenue up 16%
News | May 20, 2026

Zydus Lifesciences reports FY26 revenue of Rs. 27,148 crore, Q4 revenue up 16%

Company’s FY26 EBITDA rses 20% to Rs. 8,475 crore; Net profit grows 15% amid strong operational performance


India’s top scientific minds discuss  preparedness against emerging health threats
Policy | May 19, 2026

India’s top scientific minds discuss preparedness against emerging health threats

Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges


Telangana life sciences ecosystem reaches $145 billion valuation
Biotech | May 15, 2026

Telangana life sciences ecosystem reaches $145 billion valuation

The state has received Rs. 84,000 crore investments in the sector over two years, positioning Hyderabad among the world’s leading life sciences clusters


Vyome secures exclusive license from Impetis for selective JAK inhibitor programs
News | May 13, 2026

Vyome secures exclusive license from Impetis for selective JAK inhibitor programs

The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments


Computational tool ‘Renoir’ to decode cell communication in complex tissues
R&D | May 12, 2026

Computational tool ‘Renoir’ to decode cell communication in complex tissues

IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues